DCM Shriram (DCMSHRIRAM) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
19 Jun, 2026Executive summary
Q1 FY25 performance aligned with expectations, with strong growth in chemicals and vinyl, while sugar and ethanol faced margin pressure due to higher costs and lack of exports.
Net revenue for Q1 FY25 rose 3% year-over-year to INR 2,876 crore, with PBDIT up 49% and PAT up 77% compared to Q1 FY24.
CapEx in chemicals nearing completion, with new caustic and power capacities commissioned and new plants for hydrogen peroxide and epichlorohydrin expected to enhance efficiency.
Fenesta and Shriram Farm Solutions maintained growth momentum, while Fertilizers and Cement saw declines due to maintenance and lower prices.
A 120MW captive power plant was commissioned at the chemical complex in Jhagadia, Gujarat on June 27, 2024.
Financial highlights
Net revenues (net of excise) for Q1 FY25 were INR 2,876 crore, up from INR 2,780 crore year-over-year.
PBDIT rose 49% year-over-year to INR 274 crore; PAT reached INR 100 crore, up 77% year-over-year.
Net debt as of June 30, 2024, stood at INR 1,459 crore, up from INR 926 crore a year ago.
ROCE for the period was 14.3% (vs 13.6% for FY24).
Basic/Diluted EPS for the quarter was ₹6.43, up from ₹3.63 in Q1 FY24.
Outlook and guidance
Expectation of gradual improvement in chemicals business as industry pressures bottom out, with new capacity and power plant to improve efficiency.
Hydrogen peroxide and epichlorohydrin plants to be commissioned in Q2 and Q3 FY25, with major revenue impact from next year.
Sugar business faces margin pressure; industry seeks higher MSP and export policy continuity.
Fenesta aims for growth via new products and geographic expansion.
Normal monsoon expected to support agri-related businesses.
Latest events from DCM Shriram
- Q2 FY25 revenue up 9–10.8% YoY, PAT up 95%, major capex and interim dividend declared.DCMSHRIRAM
Q2 24/2519 Jun 2026 - FY26 delivered 12% revenue and 42% PAT growth, with major capacity expansions and high dividends.DCMSHRIRAM
Q4 25/2615 May 2026 - Q3 FY26 revenue up 13% YoY, PAT down 19% on ₹55 crore provision; dividend declared.DCMSHRIRAM
Q3 25/2613 Apr 2026 - Q3 FY25 revenue up 11%, PAT up 9%, with strong Chemicals growth and major CapEx, dividend declared.DCMSHRIRAM
Q3 24/2510 Jan 2026 - Q1 FY26 saw strong growth in revenue and profits, driven by chemicals, agri, and strategic moves.DCMSHRIRAM
Q1 25/2620 Nov 2025 - FY25 saw double-digit growth, higher dividends, and major project commissioning.DCMSHRIRAM
Q4 24/2520 Nov 2025 - Strong Q2 growth led by Chemicals, Vinyl, and Fenesta, with major expansions and profit gains.DCMSHRIRAM
Q2 25/2631 Oct 2025